These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30570421)

  • 1. Pharmacists Providing Palliative Care Services: Demonstrating a Positive Return on Investment.
    Lehn JM; Gerkin RD; Kisiel SC; O'Neill L; Pinderhughes ST
    J Palliat Med; 2019 Jun; 22(6):644-648. PubMed ID: 30570421
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicentered Evaluation of Palliative Care Pharmacists' Interventions and Outcomes in California.
    Malotte K; Naidu DR; Herndon CM; Atayee RS
    J Palliat Med; 2021 Sep; 24(9):1358-1363. PubMed ID: 33625895
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-benefit analysis with return on investment of clinical pharmacists in the Military Health System.
    Kelly S; Juneau RA; Palmrose G; Svihla IN; Phung G; Hull JR; Folmar D; Costantino R
    J Manag Care Spec Pharm; 2024 May; 30(5):456-464. PubMed ID: 38701031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Palliative Care Pharmacist Interventions and Outcomes as Part of Inpatient Palliative Care Consult Service.
    Atayee RS; Sam AM; Edmonds KP
    J Palliat Med; 2018 Dec; 21(12):1761-1767. PubMed ID: 29957096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a clinical pharmacist in a multidisciplinary intensive care unit.
    Montazeri M; Cook DJ
    Crit Care Med; 1994 Jun; 22(6):1044-8. PubMed ID: 8205814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost savings vary by length of stay for inpatients receiving palliative care consultation services.
    Starks H; Wang S; Farber S; Owens DA; Curtis JR
    J Palliat Med; 2013 Oct; 16(10):1215-20. PubMed ID: 24003991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of a prospective multi-site cohort study of palliative care consultation teams for adults with advanced cancer: Where do cost-savings come from?
    May P; Garrido MM; Cassel JB; Kelley AS; Meier DE; Normand C; Smith TJ; Morrison RS
    Palliat Med; 2017 Apr; 31(4):378-386. PubMed ID: 28156192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-maker and staff perceptions of the pharmacist's role in transitions of care programs.
    Foster AR; Gatewood SS; Kaefer TN; Goode JKR
    J Am Pharm Assoc (2003); 2019; 59(4S):S101-S105. PubMed ID: 31080151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Care Pharmacist Services Align With Payment Reform and Provider "Joy of Practice".
    Smith M
    Ann Pharmacother; 2019 Mar; 53(3):311-315. PubMed ID: 30303028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.
    O'Mahony C; Dalton K; O'Hagan L; Murphy KD; Kinahan C; Coyle E; Sahm LJ; Byrne S; Kirke C
    Int J Clin Pharm; 2024 Aug; 46(4):957-965. PubMed ID: 38814513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of a primary healthcare pharmacist.
    Kolodziejak L; Rémillard A; Neubauer S
    J Interprof Care; 2010 May; 24(3):274-84. PubMed ID: 20388026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacist intervention on clinical outcomes in the palliative care setting.
    Wilson S; Wahler R; Brown J; Doloresco F; Monte SV
    Am J Hosp Palliat Care; 2011 Aug; 28(5):316-20. PubMed ID: 21115471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
    Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
    Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan.
    Ise Y; Morita T; Katayama S; Kizawa Y
    J Pain Symptom Manage; 2014 Mar; 47(3):588-93. PubMed ID: 24018207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Return-On-Investment for Billable Pharmacist-Provided Services in the Primary Care Setting.
    Tran T; Moczygemba LR; Musselman KT
    J Pharm Pract; 2022 Dec; 35(6):916-921. PubMed ID: 34036819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a role description and competency map for pharmacists in an interprofessional care setting.
    Benson H; Lucas C; Benrimoj SI; Williams KA
    Int J Clin Pharm; 2019 Apr; 41(2):391-407. PubMed ID: 30879217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Clinical Pharmacist Service in the Hospice Setting: Financial and Clinical Impacts.
    Richter C
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):256-259. PubMed ID: 31135238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist.
    Muijrers PE; Knottnerus JA; Sijbrandij J; Janknegt R; Grol RP
    Pharm World Sci; 2003 Oct; 25(5):235-41. PubMed ID: 14584231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study.
    Howard MS; DiDonato KL; Janovick DL; Schroeder MN; Powers MF; Azzi AG; Lengel AJ
    J Am Pharm Assoc (2003); 2018; 58(4S):S30-S36.e2. PubMed ID: 30006185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.